The success of copyright’s blockbuster initially fueled a period of growth for major pharmaceutical companies, but recent shifts present a complicated scenario for shareholders. Off-patent competitors are eating into https://lucsssk295699.jts-blog.com/39805870/sildenafil-and-big-pharma-a-volatile-investment